Sensitive LC-MS method for the quantitative analysis of semaglutide and liraglutide in human plasma

Application note | 004408 Pharma Advancing anti-obesity drug development with robust quantitation of GLP-1 analogs using human plasma Authors Application benefits Hao Yang , Neloni Wijeratne , Ke Ma , 1 1 2 • Sensitive and reproducible quantitation of semaglutide…

Detection and quantification of GLP-1 analogs in human plasma: A comprehensive analytical approach Hao Yang1, Cristina Jacob1, Romain Huguet1, Min Du2 1 Thermo Fisher Scientific, San Jose, CA, United States; 2 Thermo Fisher Scientific, Lexington, MA, United States Abstract Materials…

Agilent biopharma solutions Workflows for GLP-1 Receptor Agonists and Therapeutic Peptides: Identity, Impurity, Bioanalysis, and Stability Testing Contents Raw Material Purity and Impurity Identification Analysis Bioanalysis Stability Testing Studies Contents Introduction 02 1 Raw Material Identification 03 1.1 Verification…

Automated SPE Sample Preparation for Bioanalysis of GLP-1 Analogs from Plasma Makda Araya and Chelsea Plummer Waters Corporation, Milford MA, USA _________________________________________________________________________________________________________________________________________________ RESULTS INTRODUCTION Glucagon-Like Peptide 1 (GLP-1) analogs, initially intended to treat type II diabetes Mellitus, are currently used…